Current Drug Targets - Infectious Disorders

Preface [Hot topic: HIV Drug Resistance and Approaches to New Therapies (Guest Editor: Chris Petropoulos)]
pp. i-iii(3)
Author: Goldman, Robert C.

A Review of HIV-1 Resistance to the Nucleoside and Nucleotide Inhibitors
pp. 273-281(9)
Authors: Shulman, Nancy; Winters, Mark

Resistance to HIV-1 Entry Inhibitors
pp. 283-294(12)
Authors: Olson, W. C.; Maddon, P. J.

Is Resistance Futile?
pp. 295-309(15)
Authors: Kutilek, Victoria D.; Sheeter, Dennis A.; Elder, John H.; Torbett, Bruce E.

Structural and Thermodynamic Basis of Resistance to HIV-1 Protease Inhibition: Implications for Inhibitor Design
pp. 311-328(18)
Authors: Velazquez-Campoy, Adrian; Muzammil, Salman; Ohtaka, Hiroyasu; Schon, Arne; Vega, Sonia; Freire, Ernesto

Mathematical Approaches in the Study of Viral Kinetics and Drug Resistance in HIV-1 Infection
pp. 329-344(16)
Authors: Muller, V.; Bonhoeffer, S.

Predicting the Impact of Antiretrovirals in Resource-Poor Settings: Preventing HIV Infections whilst Controlling Drug Resistance
pp. 345-353(9)
Authors: Blower, Sally; Ma, Li; Farmer, Paul; Koenig, Serena

Fitness Variations and their Impact on the Evolution of Antiretroviral Drug Resistance
pp. 355-371(17)
Authors: Menendez-Arias, Luis; Martinez, Miguel A.; Quinones-Mateu, Miguel E.; Martinez-Picado, Javier

Variety of Interpretation Systems for Human Immunodeficiency Virus Type 1 Genotyping: Confirmatory Information or Additional Confusion?
pp. 373-382(10)
Authors: Sturmer, M.; Doerr, H. W.; Preiser, W.

Anti-HIV Inhibitors Based on Nucleic Acids: Emergence of Aptamers as Potent Antivirals
pp. 383-400(18)
Authors: Joshi, P. J.; Fisher, T. S.; Prasad, V. R.